To date, 6 placebo-controlled cardiovascular outcomes trials of GLP-1 agonists in T2DM, and one in patients who are overweight/patients with obesity without diabetes, have demonstrated superiority for 3-point (MACE) reduction (Table 2)
However, if you have sensitive skin or any known allergies, it's recommended to do a patch test before regular use
Heliyon 8(11):e11622 Guo W, Wang X, Liu F, Chen S, Wang S, Zhang Q, Yuan L, Du S (2022b) Acteoside alleviates dextran sulphate sodium-induced ulcerative colitis via regulation of the HO-1/HMGB1 signaling pathway
Figure 6 depicts abundance-shifted KEGG modules and associated functional pathways
Deckert J (1997)